Dextromethorphan-bupropion (Auvelity™): Efficacy

This article was first published on August 31, 2022. It was last edited or updated on September 4, 2022. In August 2022, the United States Food and Drug Administration (FDA) approved the combination of dextromethorphan and bupropion (brand name Auvelity™) for the treatment of major depressive disorder (MDD). Note that the FDA indication is NOT…